Agranulocytosis following mapharsen therapy is sufficiently rare to make the following case reports of interest:
Case 1.—A 19 year old Negro soldier was admitted to the station hospital, Fort Dix, N. J., on Dec. 16, 1943, complaining of sore throat, malaise, chills and fever, all of two days' duration. Five weeks prior to his admission the patient had had a sore throat, mucous patches and a maculopapular rash which were considered manifestations of secondary syphilis. The Wassermann reaction was 4 plus. He was given standard antisyphilitic therapy, consisting of two injections of mapharsen weekly, beginning with 0.03 Gm. and increasing to 0.06 Gm. per dose. The patient had received five intravenous injections of mapharsen totaling 0.28 Gm. and three intramuscular injections of bismuth subsalicylate in oil totaling 1 Gm. He had received the last injection of mapharsen on December 14, with no immediate reaction. A few
KASICH M. AGRANULOCYTOSIS FOLLOWING MAPHARSEN THERAPY: REPORT OF TWO CASES. Arch Derm Syphilol. 1944;50(5):302–305. doi:10.1001/archderm.1944.01510170016003
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: